Population
30 European countries that are members of the European Influenza Surveillance Scheme (EISS)
Design
Cross-sectional
Authors
Loading...
Surveillance gaps may delay resistance detection in stockpiled antivirals; leaves open whether targeted lab investments can strengthen monitoring.
Despite widespread stockpiling of influenza antivirals in Europe, the capability of national reference laboratories to monitor antiviral susceptibility remains limited.
Meijer et al. (2007) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: